adminipi

PCI Pharma Services Completes Acquisition of Sherpa Clinical Packaging

Oct 22, 2018

PCI continues expansion of its global clinical services network to California. Philadelphia, USA – October 2, 2018 Leading global biopharmaceutical outsourcing services provider PCI Pharma Services (PCI) has announced the completion of its acquisition of Sherpa Clinical Packaging (Sherpa).   Located in San Diego, Sherpa is a recognized provider of Clinical Trial materials management services and is known for its high quality, flexibility, and speed-to-market in support of investigational studies conducted around the world.   Sherpa’s packaging, labeling, distribution, temperature-controlled storage and returns services are highly complementary to PCI and adding this key geography further strengthens PCI’s ability to support ...

Read More

PCI Clinical Services Announces New Facility Dedicated to Clinical Trial Returns

Oct 22, 2018

Continued investment at Bridgend site enables capacity expansion for segregated space in support of the Return of investigational drug products used in Clinical studies. Philadelphia, USA – October 15, 2018. Leading international pharmaceutical outsourcing services provider PCI Clinical Services (PCI) has announced the completion of a dedicated Returns Management facility at its Clinical Services Center of Excellence at Bridgend, UK.  PCI provides a full service Returns Management service for clients, providing visibility and accountability in returning investigational drug product from investigational sites at the conclusion of a clinical study. Returning and reconciling Investigational Medicinal Product (IMP) on completion of a ...

Read More

AstraZeneca to continue UK investment freeze due to Brexit uncertainty

Oct 17, 2018

Anglo-Swedish biopharma company AstraZeneca’s non-executive chairman Leif Johansson has unveiled to French newspaper La Monde that the company will continue its freeze on manufacturing investments in Britain if uncertainty over Brexit continues. Johansson told La Monde: “If a transition deal does not make clear what will happen in the future, we will maintain our decision not to invest. “A Brexit agreement will need to ensure that Britain does not become an isolated island in the middle of the Atlantic Ocean.” A spokesperson for AstraZeneca said: “The chairman was talking about a decision announced over a year ago to freeze future ...

Read More

Could treating psoriasis in the future be as easy as going online?

Oct 17, 2018

For approximately 8 million Americans, visiting a doctor regularly is the key to managing their psoriasis, a chronic inflammatory skin condition characterized by itchy or painful red patches that can appear anywhere on the body. But for some people, seeing a specialist regularly can be a monumental challenge, especially for those who live in rural or underserved communities. A new study led by the Keck School of Medicine of USC, however, raises the possibility that one day, people with psoriasis may be able to simply go online to receive their care. Published today in JAMA Network Open, the study found ...

Read More

CPhI Annual report forecasts CMOs to benefit from double digit approvals for ADCs in the next 3-years.

Oct 17, 2018

Summary of trends forecast: the next 1-3 years Novel payloads that target tumour-initiating cells on third generation ADCs could come to market in the next couple of years ADCs market forecast to expand at nearly 20% CAGR until 2030 driven by a healthy late stage pipeline. Outsourcing of ADC manufacturing will continue, with increased co-development – driven by increased needs from biotechs needing specialist development expertise and facilities. Longer term (circa 5-years) the expansion of ADCs into therapeutic areas other than oncology will be the next evolution – bioconjugation in infectious disease is one potential area Madrid, 9th October 2018: The global ...

Read More